株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙SALE
市場調査レポート

POC診断 (ポイントオブケア診断) の世界市場:2017年〜2021年

Global POC Diagnostics Market 2017-2021

発行 TechNavio (Infiniti Research Ltd.) 商品コード 325006
出版日 ページ情報 英文 117 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.77円で換算しております。
Back to Top
POC診断 (ポイントオブケア診断) の世界市場:2017年〜2021年 Global POC Diagnostics Market 2017-2021
出版日: 2017年07月05日 ページ情報: 英文 117 Pages
概要

世界のPOC診断 (ポイントオブケア診断) 市場は、2017年から2021年の間、7.95%のCAGR (複合年間成長率) で拡大することが予測されています。

当レポートでは、世界におけるPOC診断 (ポイントオブケア診断) 市場の現状分析と今後の予測を製品、エンドユーザーおよび地域別に提供しており、市場の成長因子と課題、主な動向、主要ベンダーのプロファイルなどとともにお届けします。

第1章 エグゼクティブサマリー

第2章 当レポートの調査範囲

第3章 調査手法

第4章 イントロダクション

  • 市場概要

第5章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第6章 製品別の市場分類

  • 市場概要
  • 世界のPOC血糖値検査市場
  • 世界のPOCヘモグロビンA1c (HbA1c) 検査市場
  • 世界のPOC即時心血管検査市場
  • 世界のPOC血中ガスおよび電解質市場
  • 世界のPOC感染症検査市場
  • 世界のPOC即時血液凝固検査市場
  • 世界のPOC血液検査市場
  • 世界のPOC妊娠検査市場
  • 世界のPOC検尿市場
  • 世界のPOC脂質検査市場
  • 世界のPOC薬物乱用検査市場
  • 世界のPOC検便市場

第7章 エンドユーザー別の市場分類

  • 市場概要
  • 病院・クリニック
  • 臨床診断ラボ
  • 在宅ケア
  • 世界のPOC診断市場:エンドユーザー別の購入基準の分析

第8章 地理区分

  • 市場概要
  • 南北アメリカ
  • 欧州・中東・アフリカ地域
  • アジア太平洋地域

第9章 意思決定の枠組み

第10章 市場の成長因子と課題

  • 市場成長因子
  • 市場の課題

第11章 市場動向

第12章 ベンダー情勢

  • 競合情勢

第13章 主要ベンダーの分析

  • Alere
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Danaher
  • 注目企業
  • その他の有力ベンダー

第14章 付録

  • 略語リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IRTNTR13347

About POC Diagnostics

POC diagnostic tests help in reducing the time between diagnosis and treatment of a disease. These tests are either antibody-based or microbial particle-based. Healthcare professionals or nurses collect the testing samples from the patient, perform analysis, and record the result. These tests include enzyme-linked immunosorbent assay (ELISA), agglutination tests, and lateral flow immunochromatography. In 2016, the global POC diagnostics market held 13.09% of the global IVD market.

Technavio's analysts forecast the global POC diagnostics market to grow at a CAGR of 7.95% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global POC diagnostics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales, volume and value of POC diagnostics.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global POC Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Alere,
  • F. Hoffmann-La Roche,
  • Siemens Healthineers
  • Abbott
  • PTS Diagnostics
  • Danaher

Other Prominent Vendors

  • Accriva Diagnostics
  • Aesynt
  • CoaguSense
  • Diagon
  • DiaSys
  • EKF Diagnostics
  • Epistem
  • FUJIFILM
  • Helena Laboratories
  • HemoSonics
  • iLine Microsystems
  • Jant Pharmacal
  • LifeScan
  • Micropoint Bioscience
  • Nova Biomedical
  • Philips healthcare
  • PixCell
  • Quidel
  • Radisens Diagnostics
  • Securetec
  • Detektions-Systeme
  • Sysmex
  • TaiDoc

Market driver

  • Growing focus on diagnosing life-threatening conditions
  • For a full, detailed list, view our report

Market challenge

  • Lack of skilled professionals to carry out POC diagnosis
  • For a full, detailed list, view our report

Market trend

  • Emerging technology of molecular diagnosis in POC
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Market overview
  • Global POC blood glucose diagnostics market
  • Global POC HbA1c diagnostics market
  • Global POC rapid cardiovascular diagnostics market
  • Global POC blood gas and electrolyte diagnostics market
  • Global POC infectious disease diagnostics market
  • Global POC rapid coagulation diagnostics market
  • Global POC Hematology diagnostics market
  • Global POC pregnancy diagnostics market
  • Global POC urinalysis market
  • Global POC lipid testing market
  • Global POC drug of abuse diagnostics market
  • Global POC fecal occult testing market

PART 07: Market segmentation by end-user

  • Market overview
  • Hospitals and clinics
  • Clinical diagnostic laboratories
  • Home care settings
  • Buying criteria analysis: Global POC Diagnostics market by end-users 2016

PART 08: Geographical segmentation

  • Market overview
  • Global POC diagnostic market in Americas
  • Global POC diagnostic market in EMEA
  • Global POC diagnostic market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Market challenges

PART 11: Market trends

  • Focus on next-generation technologies
  • Increasing online marketing services for POC diagnosis
  • Data management and connectivity to EHRs through interoperability

PART 12: Vendor landscape

  • Competitive landscape

PART 13: Key vendor analysis

  • Alere
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Danaher
  • Key companies to watch
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Market overview of global IVD and POC diagnostics market 2016
  • Exhibit 02: Market outline of global POC diagnostics market 2016
  • Exhibit 03: Global POC diagnostics market ($ millions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Segment life cycle of POC diagnostics market in 2016
  • Exhibit 06: POC diagnostic market segmentation by product
  • Exhibit 07: Global POC diagnostics blood glucose market 2016-2021 ($ millions)
  • Exhibit 08: Market metric analysis: POC blood glucose diagnostics market 2016
  • Exhibit 09: Global POC HbA1c diagnostics market 2016-2021 ($ millions)
  • Exhibit 10: Market metric analysis: POC HbA1c diagnostics market 2016
  • Exhibit 11: Global POC rapid cardiovascular diagnostics market 2016-2021 ($ millions)
  • Exhibit 12: Market metric analysis: Global POC rapid cardiovascular diagnostics market 2016
  • Exhibit 13: Global POC blood gas and electrolyte diagnostics market 2016-2021 ($ millions)
  • Exhibit 14: Market metric analysis: Global POC blood gas and electrolyte diagnostics market 2016
  • Exhibit 15: Global POC infectious disease diagnostics market 2016-2021 ($ millions)
  • Exhibit 16: Increased prevalence of Hepatitis in US 2015
  • Exhibit 17: Market metric analysis: Global POC infectious disease diagnostics market 2016
  • Exhibit 18: Global POC rapid coagulation diagnostics market 2016-2021 ($ millions)
  • Exhibit 19: Market metric analysis: Global POC rapid coagulation diagnostics market 2016
  • Exhibit 20: Global POC hematology diagnostics market 2016-2021 ($ millions)
  • Exhibit 21: Market metric analysis: Global POC hematology diagnostics market 2016
  • Exhibit 22: Global POC pregnancy diagnostics market 2016-2021 ($ millions)
  • Exhibit 23: Market metric analysis: Global POC pregnancy diagnostics market 2016
  • Exhibit 24: Global POC urinalysis market 2016-2021 ($ millions)
  • Exhibit 25: Market metric analysis: Global POC urinalysis market 2016
  • Exhibit 26: Global POC lipid testing market 2016-2021 ($ millions)
  • Exhibit 27: Market metric analysis: Global POC lipid testing market 2016
  • Exhibit 28: Global POC drug of abuse diagnostics market 2016-2021 ($ millions)
  • Exhibit 29: Market metric analysis: Global POC drug of abuse diagnostics market 2016
  • Exhibit 30: Global POC fecal occult testing market 2016-2021 ($ millions)
  • Exhibit 31: Market metric analysis: Global POC fecal occult testing market 2016
  • Exhibit 32: Global POC diagnostic market segmentation by end-users 2016
  • Exhibit 33: Marketing strategy analysis of global POC diagnostics market by end-users 2016
  • Exhibit 34: Market overview by hospitals and clinics 2016
  • Exhibit 35: Market overview by clinical diagnostic laboratories 2016
  • Exhibit 36: Market overview by home care settings 2016
  • Exhibit 37: Global POC diagnostics market segmentation by geography 2016 and 2021 ($ millions)
  • Exhibit 38: Market overview: POC diagnostics market in Americas 2016-2021
  • Exhibit 39: Global POC diagnostics market in Americas ($ millions)
  • Exhibit 40: The Americas: Market metrics in various countries
  • Exhibit 41: Market overview: POC diagnostics market in EMEA (2016-2021)
  • Exhibit 42: Global POC diagnostics market in EMEA ($ millions)
  • Exhibit 43: Market overview: POC diagnostics market in APAC 2016-2021
  • Exhibit 44: Global POC diagnostics market in APAC ($ millions)
  • Exhibit 45: Global increasing percentage of older adult population 2015-2030
  • Exhibit 28: Favorable reimbursements by Abbott's cartridge in POCT for end-users in US
  • Exhibit 46: Complete list of products recalled by Alere in 2016
  • Exhibit 47: Competitive structure analysis of global POC diagnostics market 2016
  • Exhibit 48: Market penetration of various global POC diagnostic market providers 2017
  • Exhibit 49: Strategic success factors of companies in global POC diagnostic market 2017
  • Exhibit 50: Alere: Strength assessment
  • Exhibit 51: Alere: Strategy assessment
  • Exhibit 52: Alere: Opportunity assessment
  • Exhibit 53: F. Hoffmann-La Roche: Strength assessment
  • Exhibit 54: F. Hoffmann-La Roche: Strategy assessment
  • Exhibit 55: F. Hoffmann-La Roche: Opportunity assessment
  • Exhibit 56: Siemens Healthineers: Strength assessment
  • Exhibit 57: Siemens Healthineers: Strategy assessment
  • Exhibit 58: Siemens Healthineers: Opportunity assessment
  • Exhibit 59: Danaher: Key highlights
  • Exhibit 60: Danaher: Strength assessment
  • Exhibit 61: Danaher: Strategy assessment
  • Exhibit 62: Danaher: Opportunity assessment
  • Exhibit 63: Abbott: Company assessment
  • Exhibit 64: PTS diagnostics: Company assessment
Back to Top